Market Overview:
The global cell line development services market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for bioproduction and recombinant protein therapeutics, tissue engineering & regenerative medicines, drug discovery, and toxicity testing applications. In addition, the growing demand for personalized medicines is also contributing to the growth of this market. The media and reagents segment is expected to hold the largest share of the global cell line development services market in 2018. This segment is mainly driven by rising demand for optimized media formulations and reagents that are specific to certain applications such as bioproduction, recombinant protein therapeutics, tissue engineering & regenerative medicines, drug discovery etc., across different regions. Geographically, North America held the largest share of the global cell line development services market in 2017 followed by Europe and Asia Pacific respectively.
Product Definition:
Cell line development services refers to the process of developing a new cell line for use in research or manufacturing. The importance of cell line development services is that it allows for the creation of cells lines that are specific to a particular application or need. This can be important for researchers who need cells lines that are more representative of actual tissue, or for manufacturers who need cells lines that can produce large quantities of a specific molecule.
Media and Reagents:
Media and reagents are the two key elements in cell line development. The growth factor for media and reagent market is the need to develop high-quality, safe, and cost effective products. With technological advancements Media & Reagents have become less expensive which has increased its application across various fields of biotechnology including pharmaceuticals & medical research.
Equipment:
Equipment is the most important part of cell line development services. It's a collection of reagents and devices used for manipulation in cell culture. Cell line development requires instruments that are capable to grow cells at an exponential rate, which can be achieved with the help of bioreactors and centrifuges along with other essential equipment like microscopes, pipettes, shakers, etc.
Application Insights:
The bioproduction segment dominated the global market in terms of revenue in 2017. This is attributed to rising demand for cell line development services from various industries such as pharmaceutical, biotechnology, and food & beverage. The recombinant protein therapeutics segment is expected to witness lucrative growth over the forecast period owing to increasing R&D activities pertaining to proteins and their derivatives for treating several diseases including cancer.
Cell line development plays a significant role in tissue engineering and regenerative medicine applications due largely to growing usage of stem cells derived from induced pluripotent stem cells (iPSCs). Furthermore, growing number of clinical trials using iPSC-based models for drug discovery are further anticipated fuel industry expansion over the forecast period. Growing toxicity testing application sector due largely on-going government initiatives coupled with high demand for novel drugs are further anticipated fuel industry expansion over the forecast period (Ref.#5).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of biotechnology and biopharmaceutical firms, which are engaged in drug discovery and development processes. Moreover, increasing government funding for R&D activities pertaining to cell line development is also expected to propel regional growth over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising investments by various pharmaceutical companies for drug discovery and development processes. In addition, growing awareness regarding stem cell therapy applications is further expected boost regional demand during the estimated time frame. However, stringent regulations imposed on CROs by governments may hinder progress at times; this factor alone may account for a relatively smaller share compared with other regions’ estimates as it depends upon many factors such as GDP per capita (PPP) or total Factor Productivity (TFP).
Growth Factors:
- Increasing demand for biologics and biosimilars
- Rising prevalence of chronic diseases
- Technological advancements in cell line development services
- Growing investments in life sciences sector
- Rising number of collaborations and partnerships among market players
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Line Development Services Market Research Report
By Type
Media and Reagents, Equipment
By Application
Bioproduction, Recombinant Protein Therapeutics, Tissue Engineering & Regenerative Medicines, Drug Discovery, Toxicity Testing
By Companies
Lonza, MabPlex, Thermo Fisher, Solentim, Sigma-Aldrich, Selexis, Corning, Sartorius
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Cell Line Development Services Market Report Segments:
The global Cell Line Development Services market is segmented on the basis of:
Types
Media and Reagents, Equipment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bioproduction, Recombinant Protein Therapeutics, Tissue Engineering & Regenerative Medicines, Drug Discovery, Toxicity Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza
- MabPlex
- Thermo Fisher
- Solentim
- Sigma-Aldrich
- Selexis
- Corning
- Sartorius
Highlights of The Cell Line Development Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Media and Reagents
- Equipment
- By Application:
- Bioproduction
- Recombinant Protein Therapeutics
- Tissue Engineering & Regenerative Medicines
- Drug Discovery
- Toxicity Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Line Development Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell Line Development Services (CLDS) is a global biotechnology company that provides innovative cell line development and manufacturing services to the life sciences research community. CLDS' core capabilities include the development of human embryonic stem cells, induced pluripotent stem cells, and other primary cell lines; the manufacture of high-quality recombinant proteins; and the provision of customized support services for protein production.
Some of the major players in the cell line development services market are Lonza, MabPlex, Thermo Fisher, Solentim, Sigma-Aldrich, Selexis, Corning, Sartorius.
The cell line development services market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cell Line Development Services Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cell Line Development Services Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cell Line Development Services Market - Supply Chain
4.5. Global Cell Line Development Services Market Forecast
4.5.1. Cell Line Development Services Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cell Line Development Services Market Size (000 Units) and Y-o-Y Growth
4.5.3. Cell Line Development Services Market Absolute $ Opportunity
5. Global Cell Line Development Services Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Cell Line Development Services Market Size and Volume Forecast by Type
5.3.1. Media and Reagents
5.3.2. Equipment
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Cell Line Development Services Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Cell Line Development Services Market Size and Volume Forecast by Application
6.3.1. Bioproduction
6.3.2. Recombinant Protein Therapeutics
6.3.3. Tissue Engineering & Regenerative Medicines
6.3.4. Drug Discovery
6.3.5. Toxicity Testing
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Cell Line Development Services Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Cell Line Development Services Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Cell Line Development Services Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Cell Line Development Services Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Cell Line Development Services Demand Share Forecast, 2019-2029
9. North America Cell Line Development Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Cell Line Development Services Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Cell Line Development Services Market Size and Volume Forecast by Application
9.4.1. Bioproduction
9.4.2. Recombinant Protein Therapeutics
9.4.3. Tissue Engineering & Regenerative Medicines
9.4.4. Drug Discovery
9.4.5. Toxicity Testing
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Cell Line Development Services Market Size and Volume Forecast by Type
9.7.1. Media and Reagents
9.7.2. Equipment
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Cell Line Development Services Demand Share Forecast, 2019-2029
10. Latin America Cell Line Development Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Cell Line Development Services Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Cell Line Development Services Market Size and Volume Forecast by Application
10.4.1. Bioproduction
10.4.2. Recombinant Protein Therapeutics
10.4.3. Tissue Engineering & Regenerative Medicines
10.4.4. Drug Discovery
10.4.5. Toxicity Testing
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Cell Line Development Services Market Size and Volume Forecast by Type
10.7.1. Media and Reagents
10.7.2. Equipment
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Cell Line Development Services Demand Share Forecast, 2019-2029
11. Europe Cell Line Development Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Cell Line Development Services Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Cell Line Development Services Market Size and Volume Forecast by Application
11.4.1. Bioproduction
11.4.2. Recombinant Protein Therapeutics
11.4.3. Tissue Engineering & Regenerative Medicines
11.4.4. Drug Discovery
11.4.5. Toxicity Testing
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Cell Line Development Sevices Market Size and Volume Forecast by Type
11.7.1. Media and Reagents
11.7.2. Equipment
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Cell Line Development Services Demand Share, 2019-2029
12. Asia Pacific Cell Line Development Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Cell Line Development Services Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Cell Line Development Services Market Size and Volume Forecast by Application
12.4.1. Bioproduction
12.4.2. Recombinant Protein Therapeutics
12.4.3. Tissue Engineering & Regenerative Medicines
12.4.4. Drug Discovery
12.4.5. Toxicity Testing
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Cell Line Development Services Market Size and Volume Forecast by Type
12.7.1. Media and Reagents
12.7.2. Equipment
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Cell Line Development Services Demand Share, 2019-2029
13. Middle East & Africa Cell Line Development Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Cell Line Development Services Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Cell Line Development Services Market Size and Volume Forecast by Application
13.4.1. Bioproduction
13.4.2. Recombinant Protein Therapeutics
13.4.3. Tissue Engineering & Regenerative Medicines
13.4.4. Drug Discovery
13.4.5. Toxicity Testing
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Cell Line Development Services Market Size and Volume Forecast by Type
13.7.1. Media and Reagents
13.7.2. Equipment
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Cell Line Development Services Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Cell Line Development Services Market: Market Share Analysis
14.2. Cell Line Development Services Distributors and Customers
14.3. Cell Line Development Services Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Lonza
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. MabPlex
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Thermo Fisher
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Solentim
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sigma-Aldrich
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Selexis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Corning
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sartorius
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
